• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association Between Aortic Dissection and Systemic Exposure of Vascular Endothelial Growth Factor Pathway Inhibitors in the Japanese Adverse Drug Event Report Database.

作者信息

Oshima Yasuo, Tanimoto Tetsuya, Yuji Koichiro, Tojo Arinobu

机构信息

From The Institute of Medical Science, the University of Tokyo, Japan (Y.O., K.Y., A.T.); and Jyoban Hospital of Tokiwa Foundation, Fukushima, Japan (T.T.).

出版信息

Circulation. 2017 Feb 21;135(8):815-817. doi: 10.1161/CIRCULATIONAHA.116.025144.

DOI:10.1161/CIRCULATIONAHA.116.025144
PMID:28223329
Abstract
摘要

相似文献

1
Association Between Aortic Dissection and Systemic Exposure of Vascular Endothelial Growth Factor Pathway Inhibitors in the Japanese Adverse Drug Event Report Database.日本药品不良事件报告数据库中主动脉夹层与血管内皮生长因子通路抑制剂全身暴露之间的关联
Circulation. 2017 Feb 21;135(8):815-817. doi: 10.1161/CIRCULATIONAHA.116.025144.
2
Aortic Dissection and Cardiac Dysfunction Emerged Coincidentally During the Long-Term Treatment with Angiogenesis Inhibitors for Metastatic Renal Cell Carcinoma.在使用血管生成抑制剂对转移性肾细胞癌进行长期治疗期间，主动脉夹层和心脏功能障碍同时出现。
Int Heart J. 2018 Sep 26;59(5):1174-1179. doi: 10.1536/ihj.17-461. Epub 2018 Aug 29.
3
Vascular Endothelial Growth Factor Inhibitors and the Risk of Aortic Aneurysm and Aortic Dissection.血管内皮生长因子抑制剂与主动脉瘤和主动脉夹层的风险
JAMA Netw Open. 2024 Mar 4;7(3):e240940. doi: 10.1001/jamanetworkopen.2024.0940.
4
Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab.一名患有前列腺癌且正在接受含贝伐单抗化疗的高血压患者发生急性主动脉夹层。
Acta Oncol. 2008;47(8):1600-1. doi: 10.1080/02841860801978905.
5
[Oral drugs inhibiting the VEGF pathway].[抑制VEGF通路的口服药物]
Bull Cancer. 2007 Jul;94 Spec No:S180-90.
6
Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors.心血管毒性：血管内皮生长因子信号通路抑制剂最佳给药的线索
Target Oncol. 2009 Apr;4(2):67-76. doi: 10.1007/s11523-009-0106-0. Epub 2009 Apr 17.
7
Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer Patients.探讨抗血管生成药物治疗非小细胞肺癌患者的获益/风险。
Clin Cancer Res. 2017 Mar 1;23(5):1137-1148. doi: 10.1158/1078-0432.CCR-16-1968. Epub 2016 Dec 9.
8
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.雷莫芦单抗（IMC-1121B）的 I 期药代动力学和生物学研究，雷莫芦单抗是一种针对血管内皮生长因子受体-2 的全人源免疫球蛋白 G1 单克隆抗体。
J Clin Oncol. 2010 Feb 10;28(5):780-7. doi: 10.1200/JCO.2009.23.7537. Epub 2010 Jan 4.
9
Anti-VEGF therapies in the clinic.抗血管内皮生长因子治疗的临床应用。
Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a006577. doi: 10.1101/cshperspect.a006577.
10
Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.当前癌症个体化抗血管生成治疗的关注点与挑战。
Expert Rev Anticancer Ther. 2009 Oct;9(10):1413-6. doi: 10.1586/era.09.116.

引用本文的文献

1
Mesenteric Artery Dissection Aneurysm Associated with Apatinib in a Prostate Cancer Patient: A Case Report and Literature Review.一名前列腺癌患者中与阿帕替尼相关的肠系膜动脉夹层动脉瘤：病例报告及文献综述
Res Rep Urol. 2025 Aug 6;17:263-270. doi: 10.2147/RRU.S523768. eCollection 2025.
2
Potential synergistic effects of lenvatinib and aspirin in aortic dissection: a case report and literature review.乐伐替尼与阿司匹林在主动脉夹层中的潜在协同作用：一例报告及文献综述
Front Oncol. 2025 Apr 22;15:1520770. doi: 10.3389/fonc.2025.1520770. eCollection 2025.
3
Risk of artery dissection during systemic exposure to vascular endothelial growth factor pathway inhibitors.
全身暴露于血管内皮生长因子通路抑制剂期间发生动脉夹层的风险。
Clin Transl Sci. 2024 Dec;17(12):e70096. doi: 10.1111/cts.70096.
4
Autoimmune complications of tyrosine kinase inhibitors in cancer therapy: Clinical insights, mechanisms, and future perspectives.癌症治疗中酪氨酸激酶抑制剂的自身免疫并发症：临床见解、机制和未来展望。
Medicine (Baltimore). 2024 Oct 4;103(40):e39928. doi: 10.1097/MD.0000000000039928.
5
Developmental endothelial locus 1: the present and future of an endogenous factor in vessels.发育性内皮位点1：血管内一种内源性因子的现状与未来
Front Physiol. 2024 Aug 9;15:1347888. doi: 10.3389/fphys.2024.1347888. eCollection 2024.
6
Acute aortic catastrophe caused by cardiovascular oncological manipulation by tyrosine kinase inhibitors with immune checkpoint blockades: a case report and literature review.酪氨酸激酶抑制剂联合免疫检查点阻断剂进行心血管肿瘤学操作引发的急性主动脉灾难：一例报告及文献综述
Eur Heart J Case Rep. 2024 Apr 5;8(4):ytae169. doi: 10.1093/ehjcr/ytae169. eCollection 2024 Apr.
7
Roles of pyroptosis and immune infiltration in aortic dissection.细胞焦亡与免疫浸润在主动脉夹层中的作用。
Front Mol Biosci. 2024 Mar 19;11:1277818. doi: 10.3389/fmolb.2024.1277818. eCollection 2024.
8
Vascular Endothelial Growth Factor Inhibitors and the Risk of Aortic Aneurysm and Aortic Dissection.血管内皮生长因子抑制剂与主动脉瘤和主动脉夹层的风险
JAMA Netw Open. 2024 Mar 4;7(3):e240940. doi: 10.1001/jamanetworkopen.2024.0940.
9
Aneurysm and Artery Dissection After Oral VEGFR-TKI Use in Adults With Cancer.成人癌症患者口服 VEGFR-TKI 后发生的动脉瘤和动脉夹层。
JAMA Netw Open. 2023 Nov 1;6(11):e2345977. doi: 10.1001/jamanetworkopen.2023.45977.
10
Aortic dissection induced by vascular endothelial growth factor inhibitors.血管内皮生长因子抑制剂诱发的主动脉夹层。
Front Pharmacol. 2023 Jun 22;14:1189910. doi: 10.3389/fphar.2023.1189910. eCollection 2023.